Drug Type Chemical drugs |
Synonyms- |
Target |
Action inhibitors |
Mechanism CDK11B inhibitors(cyclin dependent kinase 11B inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ewing Sarcoma | Preclinical | United States | 30 Apr 2025 |